Range
- - -
Vol / Avg.
-/0.4K
Div / Yield
-
52 Wk
3.14 - 18.1
Mkt Cap
109.8M
Payout Ratio
-
Open
-
P/E
-
Shares
35M
Outstanding
-
Total Float
-
There is no Press for this Ticker
Orphazyme AS is a late-stage biopharmaceutical company harnessing the amplification of Heat Shock Proteins. It is engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for four severe orphan diseases: Niemann-Pick disease Type C (NPC), Gaucher disease, Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Orphazyme Questions & Anwsers

Q

How do I buy Orphazyme (OZYMF) stock?

A

You can purchase shares of Orphazyme (OTCPK: OZYMF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Orphazyme's (OZYMF) competitors?

A

There are no as such competitors for Orphazyme.

Q

What is the target price for Orphazyme (OZYMF) stock?

A

There is no analysis for Orphazyme

Q

Current Stock Price for Orphazyme (OZYMF)?

A

The stock price for Orphazyme (OTCPK: OZYMF) is $3.14 last updated Wed Dec 01 2021 18:14:18 GMT+0000 (Coordinated Universal Time).

Q

Does Orphazyme (OZYMF) pay a dividend?

A

There are no upcoming dividends for Orphazyme.

Q

When is Orphazyme (OTCPK:OZYMF) reporting earnings?

A

Orphazyme does not have any upcoming earnings scheduled.

Q

Is Orphazyme (OZYMF) going to split?

A

There is no upcoming split for Orphazyme.

Q

What sector and industry does Orphazyme (OZYMF) operate in?

A

Orphazyme is in the sector and industry. They are listed on the OTCPK.